Insider filing
Traded Oct 13 · filed 20 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TPST · NASDAQ · Pharmaceutical Preparations
Tempest Therapeutics (TPST) · oqro.io/stocks/TPST · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.287−0.0189 (−6.18%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Including 13 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Oct 13 · filed 20 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 22 · filed 10 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Mar 24, 2026 · largest single transaction 231K
Mar 24, 2026231K
DetailsOfficial recordMar 24, 2026
Insider filing
Traded Jun 4 · filed 13 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 4 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Bought outside the usual windowTraded Mar 24 · filed 1 day later
Since the trade −83.6% · S&P 500 +5.6% · to Nov 20
Bought 70% below the 52-week high, RSI 32, 48% under its 200-day average, 16 points ahead of the S&P 500 over 3 months
Insider filing
Traded Feb 4 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 27 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 27 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 27 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 27 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
The CEO of Tempest Therapeutics paid $500K out of pocket for Tempest Therapeutics shares.
1 open-market purchase and 0 open-market sales by insiders of TPST between Feb 28, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 13, 2026.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 13, 2026 | None | None | None |
| Aug 13, 2026 | None | None | None |
| May 14, 2026 | None | None | None |
| Mar 30, 2026 | 1 purchase | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies